American Society of Clinical Oncology

SHERPA: White

People

  1. De Angelis
    De Angelis
  2. Panageas
    Panageas
  3. Yahalom
    Yahalom
  4. Correa
    Correa
  5. Gavrilovic
    Gavrilovic
  6. Gutin
    Gutin
  7. Karimi
    Karimi
  8. Nolan
    Nolan
  9. Reiner
    Reiner
  10. Kaley
    Kaley

Groups

  1. Tow Center for Developmental Oncology (TCDO) (29)
  2. Survivorship Research (13)
  3. Biostatistics Service (12)
  4. Epidemiology and Biostatistics (12)
  5. Population Sciences Research Program (12)
  6. Radiation Oncology, Department of (12)
  7. Radiology, Department of (8)
  8. Neuroradiology Service (7)
  9. GSK Faculty (5)
  10. Multidisciplinary Brain Metastasis Program (4)
Search Within
  1. "Lauren Abrey"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (19)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (29)
  2. Survivorship Research (13)
  3. Biostatistics Service (12)
  4. Epidemiology and Biostatistics (12)
  5. Population Sciences Research Program (12)
  6. Radiation Oncology, Department of (12)

More Groups

People
  1. Lauren Abrey (57)
  2. Lisa De Angelis (29)
  3. Antonio Omuro (12)
  4. Joachim Yahalom (12)
  5. Katherine Panageas (12)
  6. Andrew Lassman (9)

More People

Years
  1. 2023 (1)
  2. 2013 (2)
  3. 2012 (1)
  4. 2011 (3)
  5. 2010 (6)
  6. 2009 (10)

More Years

Publications
  1. Journal of Clinical Oncology (57)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
    Journal Article

    Friedman, H. S.; Prados, M. D.; Wen, P. Y.; Mikkelsen, T.; Schiff, D.; Abrey, L. E.; Yung, W. K. A.; Paleologos, N.; Nicholas, M. K.; Jensen, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses
    Meeting Abstract

    Huse, J. T.; Beal, K.; Zhang, J.; Kastenhuber, E. R.; Kaley, T. J.; Abrey, L. E.; Gutin, P. H.; Brennan, C. W.; Omuro, A. M. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
    Journal Article

    Morris, P. G.; Correa, D. D.; Yahalom, J.; Raizer, J. J.; Schiff, D.; Grant, B.; Grimm, S.; Lai, R. K.; Reiner, A. S.; Panageas, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01
    Meeting Abstract

    Nayak, L.; Abrey, L. E.; Drappatz, J.; Gilbert, M. R.; Reardon, D. A.; Lamborn, K.; Wen, P. Y.; Prados, M.; DeAngelis, L. M.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
    Meeting Abstract

    Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Prognostic factors for glioblastoma (GBM) in individuals age 70 and older: A study of 446 patients from two tertiary centers
    Meeting Abstract

    Scott, J. G.; Chao, S. T.; Suh, J. H.; Cooper, A.; Reiner, A. S.; Nayak, L.; Panageas, K.; Abrey, L. E.; Iwamoto, F. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M.; Beal, K.; Karimi, S.; Chan, T. A.; Panageas, K.; Nayak, L.; Seko, B.; DeAngelis, L. M.; Abrey, L. E.; Gutin, P. H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of sunitinib in patients with non-small cell lung cancer (NSCLC) and irradiated brain metastases: Final efficacy and safety results
    Meeting Abstract

    Novello, S.; Camps, C.; Grossi, F.; Mazieres, J.; Abrey, L. E.; Vernejoux, J.; Thall, A. D.; Usari, T.; Chao, R. C.; Scagliotti, G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save